Little cells, big puzzle: CAR T-cell therapy’s journey from bench to bedside

The success of India’s first Chimeric Antigen Receptor (CAR) T-cell therapy is the newest feather in developing an indigenous personalized treatment for cancer. Researchers at the Indian Institute of Technology, Bombay (IITB) developed this cost-effective way to treat cancer by isolating T cells, a subset of immune cells from the patients, which were modified…